Review
Published on 30 Jun 2020
GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.00967
- 39,088 views
- 103 citations
64 articles related to "Glp 1ras"
Articles
Review
Published on 14 Jun 2021
The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis Treatment
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2021.697442
- 18,140 views
- 56 citations
Original Research
Published on 13 Nov 2024
Glucagon-like peptide-1 receptor agonists and the risk of erectile dysfunction: a drug target Mendelian randomization study
in Reproduction
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1448394
- 6,727 views
- 8 citations
Review
Published on 24 Jul 2025
Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1618079
- 6,405 views
- 3 citations
Mini Review
Published on 06 Jul 2022
Glucagon-Like Peptide-1 Receptor Agonists as Potential Myelination-Inducible and Anti-Demyelinating Remedies
in Molecular and Cellular Pathology
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2022.950623
- 13,882 views
- 26 citations
Original Research
Published on 05 Dec 2024
Risk factor screening and prediction modeling of gastrointestinal adverse reactions caused by GLP-1RAs
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1502050
- 2,738 views
- 5 citations
Original Research
Published on 14 Feb 2023
Systematic investigation of the underlying mechanisms of GLP-1 receptor agonists to prevent myocardial infarction in patients with type 2 diabetes mellitus using network pharmacology
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1125753
- 7,027 views
- 12 citations
Review
Published on 23 Aug 2021
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2021.721135
- 204,076 views
- 376 citations
Review
Published on 24 Apr 2024
Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1396656
- 6,721 views
- 11 citations
Original Research
Published on 01 Mar 2022
Lipidomic Analysis Reveals the Protection Mechanism of GLP-1 Analogue Dulaglutide on High-Fat Diet-Induced Chronic Kidney Disease in Mice
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.777395
- 9,949 views
- 13 citations
Systematic Review
Published on 02 Jan 2026
The potential role of GLP-1 receptor agonists in substance use disorders – a systematic review
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1702448
- 2,437 views
Review
Published on 13 Oct 2025
GLP-1 receptor agonists synergistic effects of metabolic reprogramming and cardioprotection
in Diabetes: Molecular Mechanisms
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1614726
- 2,523 views
- 2 citations
Review
Accepted on 19 Jan 2026
Research on Epicardial Adipose Tissue as AF's Metabolic Therapeutic Target: Focus on GLP-1 Receptor Agonists
in Cardiac Rhythmology
Frontiers in Cardiovascular Medicine
- 146 views
Mini Review
Published on 24 Jun 2025
Research on the effects of GLP-1 receptor agonists in treating cognitive dysfunction and gait disorders in elderly patients with diabetes
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1607443
- 3,164 views
- 1 citation
Review
Published on 06 Nov 2018
Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2018.00649
- 22,392 views
- 82 citations
Review
Published on 01 Mar 2022
Possible Mechanisms Underlying the Effects of Glucagon-Like Peptide-1 Receptor Agonist on Cocaine Use Disorder
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.819470
- 14,205 views
- 25 citations